McGary LHF, Vardhana SA.  2022.  Vive la Résistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection.. Cancer Discov. 12(4):892-894.

Bu W, M Joyce G, Nguyen H, Banh DV, Aguilar F, Tariq Z, Yap MLan, Tsujimura Y, Gillespie RA, Tsybovsky Y et al..  2019.  Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells.. Immunity. 50(5):1305-1316.e6.

Weizman O-E, Song E, Adams NM, Hildreth AD, Riggan L, Krishna C, Aguilar OA, Leslie CS, Carlyle JR, Sun JC et al..  2019.  Mouse cytomegalovirus-experienced ILC1s acquire a memory response dependent on the viral glycoprotein m12.. Nat Immunol. 20(8):1004-1011.

Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS, von Saucken VE, Williams RY, J Karlo C, Moutinho M et al..  2018.  The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.. Mol Neurodegener. 13(1):29.

Bonham LW, Sirkis DW, Fan J, Aparicio RE, Tse M, Ramos EMarisa, Wang Q, Coppola G, Rosen HJ, Miller BL et al..  2017.  Identification of a rare coding variant in TREM2 in a Chinese individual with Alzheimer's disease.. Neurocase. 23(1):65-69.

Sirkis DW, Aparicio RE, Schekman R.  2017.  Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER-Golgi intermediate compartment.. Mol Biol Cell. 28(20):2723-2733.

Escorcia FE, Postow MA, Barker CA.  2017.  Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further Investigation.. Cancer J. 23(1):32-39.

Jay TR, von Saucken VE, Landreth GE.  2017.  TREM2 in Neurodegenerative Diseases.. Mol Neurodegener. 12(1):56.

Sirkis DW, Bonham LW, Aparicio RE, Geier EG, Ramos EMarisa, Wang Q, Karydas A, Miller ZA, Miller BL, Coppola G et al..  2016.  Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression.. Acta Neuropathol Commun. 4(1):98.

Argaw ATadesse, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG et al..  2012.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.. J Clin Invest. 122(7):2454-68.